Literature DB >> 22018643

Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.

Miho Tanaka1, Hideki Ishii, Toru Aoyama, Hiroshi Takahashi, Takanobu Toriyama, Hirotake Kasuga, Kyosuke Takeshita, Daiji Yoshikawa, Tetsuya Amano, Toyoaki Murohara.   

Abstract

BACKGROUND: Ankle brachial pressure index (ABPI) and pulse wave velocity (PWV) have been widely recognized as a marker of systemic atherosclerosis. We examined whether ABPI and brachial-ankle PWV (baPWV) predict individual cardiovascular events in patients on maintenance hemodialysis (HD).
METHODS: We prospectively followed-up 445 HD patients undergoing both ABPI and baPWV measurements for up to 5 years. They were divided into 2 groups [group with ABPI > 0.9 to ≤ 1.3 (n = 328) and group with ABPI ≤ 0.9 or >1.3 (n = 117)] and were also divided into tertiles according to the baPWV level (T1: <1850 cm/s; T2: 1850-2310 cm/s and T3: ≥ 2310 cm/s).
RESULTS: During the follow-up period (mean 43 ± 17 months), 206 cardiovascular events [cardiac event: 125 (28.1%), cerebrovascular events: 39 (8.8%), and peripheral arterial events: 42 (9.4%)] occurred, and 36 (8.1%) and 42 (9.4%) patients experienced cardiovascular and non-cardiovascular deaths, respectively. Cox multivariable analysis showed that presence of ABPI ≤ 0.9 or >1.3 was a significant predictor of cardiac events [hazard ratio (HR) 1.78, 95% confidential interval (CI) 1.27-2.49, p = 0.0008], cerebrovascular event (HR 1.95, 95%CI 1.13-3.36, p = 0.017), peripheral arterial event (HR 3.64, 95%CI 2.10-6.29, p < 0.0001), composite endpoint of cardiovascular events (HR 2.22, 95%CI 1.64-2.99, p < 0.0001), cardiovascular mortality (HR 2.42, 95%CI 1.44-4.06, p = 0.0008) and all-cause mortality (HR 1.52, 95%CI 1.03-2.25, p = 0.037). However, baPWV did not predict cardiovascular events on multivariate analysis.
CONCLUSION: ABPI but not baPWV is useful for risk stratification of systemic atherosclerotic morbidity and mortality in HD patients. Furthermore, ABPI could predict not only individual peripheral arterial events but also cardiac and cerebrovascular events.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018643     DOI: 10.1016/j.atherosclerosis.2011.09.037

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  The relationship of brachial-ankle pulse wave velocity to future cardiovascular disease events in the general Japanese population: the Takashima Study.

Authors:  N Takashima; T C Turin; K Matsui; N Rumana; Y Nakamura; A Kadota; Y Saito; H Sugihara; Y Morita; M Ichikawa; K Hirose; K Kawakani; N Hamajima; K Miura; H Ueshima; Y Kita
Journal:  J Hum Hypertens       Date:  2013-10-31       Impact factor: 3.012

Review 2.  Abnormal ankle-brachial index and risk of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis.

Authors:  Hai-Yan Chen; Fang Wei; Li-Hua Wang; Zhe Wang; Jia Meng; Hai-Bo Yu; Rui-Ning Zhang; Gui-Jiang Sun; Ai-Li Jiang; Lin Wang
Journal:  J Nephrol       Date:  2017-02-15       Impact factor: 3.902

Review 3.  Brachial-Ankle Pulse Wave Velocity: Background, Method, and Clinical Evidence.

Authors:  Masanori Munakata
Journal:  Pulse (Basel)       Date:  2016-02-05

4.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

5.  Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Yen-Hsun Chen; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Int Urol Nephrol       Date:  2015-07-22       Impact factor: 2.370

6.  Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Chen-Tung Lien; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Clin Exp Nephrol       Date:  2014-12-24       Impact factor: 2.801

7.  Short-Term Prognostic Impact of Arterial Stiffness in Older Adults Without Prevalent Cardiovascular Disease.

Authors:  Esther D Kim; Shoshana H Ballew; Hirofumi Tanaka; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Hypertension       Date:  2019-11-04       Impact factor: 10.190

Review 8.  Arterial Stiffening and Clinical Outcomes in Dialysis Patients.

Authors:  Akihiko Kato
Journal:  Pulse (Basel)       Date:  2015-05-14

9.  Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.

Authors:  Terumi Higuchi; Masanori Abe; Toshio Yamazaki; Mari Mizuno; Erina Okawa; Hideyuki Ando; Osamu Oikawa; Kazuyoshi Okada; Fumito Kikuchi; Masayoshi Soma
Journal:  Nutrients       Date:  2014-12-22       Impact factor: 5.717

10.  Ankle-brachial index: a simple way to predict mortality among patients on hemodialysis--a prospective study.

Authors:  Zaida Noemy Cabrera Jimenez; Benedito Jorge Pereira; João Egidio Romão; Sonia Cristina da Silva Makida; Hugo Abensur; Rosa Maria Affonso Moyses; Rosilene Motta Elias
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.